David Lebovitz
Stock Analyst at Citigroup
(2.48)
# 802
Out of 5,370 analysts
127
Total ratings
76.36%
Success rate
17.23%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
BMRN Biomarin Pharmaceuti... | Maintains: Neutral | 82 78 | 55.87 | 39.61% | 4 | May 2, 2025 | |
ALNY Alnylam Pharmaceutic... | Maintains: Strong Buy | 338 351 | 304.92 | 15.11% | 31 | Mar 21, 2025 | |
MDGL Madrigal Pharmaceuti... | Maintains: Strong Buy | 378 469 | 284.42 | 64.9% | 4 | Feb 27, 2025 | |
CRNX Crinetics Pharmaceut... | Maintains: Strong Buy | 70 74 | 30.94 | 139.17% | 2 | Nov 14, 2024 | |
MIRM Mirum Pharmaceutical... | Maintains: Strong Buy | 37 38 | 49.96 | -23.94% | 1 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 29 17 | 51.63 | -67.07% | 5 | Oct 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 111 92 | 128.18 | -28.23% | 6 | Feb 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 57 54 | 61.85 | -12.69% | 5 | Aug 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 408 372 | n/a | n/a | 5 | May 14, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 11 10 | n/a | n/a | 5 | May 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 38 35 | 35.43 | -1.21% | 6 | May 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 16 17 | 1.5 | 1033.33% | 11 | Apr 30, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 12 11 | 0.65 | 1592.31% | 7 | Feb 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 193 220 | n/a | n/a | 5 | Feb 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 50 500 | n/a | n/a | 2 | Dec 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 45 44 | n/a | n/a | 10 | Nov 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 194 199 | 177.4 | 12.18% | 11 | Nov 13, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 510 480 | 4.54 | 10472.69% | 2 | Nov 3, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 27 26 | n/a | n/a | 2 | Aug 13, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 119 129 | n/a | n/a | 3 | Mar 6, 2018 |